China-US M&A

China-US M&A deals meet mixed reviews

US company Medtronic plans to buy China’s KangHui Medical that makes orthopaedic implants, while Chinese wind company Ralls Corp is ordered to divest its interest in a US wind farm due to national security.
<div style="text-align: left;">
Medtronic's Beijing patient care centre
</div>
<div style="text-align: left;"> Medtronic's Beijing patient care centre </div>

Before the long weekend holiday in Hong Kong and China last week, Minneapolis-based Medtronic agreed to pay $816 million for China’s KangHui Medical, which makes implants to treat orthopaedic conditions. It is a bid to win a piece of the pie in China’s healthcare market.

¬ Haymarket Media Limited. All rights reserved.

Sign in to read on!

Registered users get 2 free articles in 30 days.

Subscribers have full unlimited access to FinanceAsia.

Not signed up? New users get 2 free articles per month, plus a 7-day unlimited free trial.

Questions?
See here for more information on licences and prices, or contact [email protected].

Share our publication on social media
Share our publication on social media